Pradeepa Yoganathan
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema (NCT03629210) | Pradeepa Yoganathan | 2019-09-01 |
Track Pradeepa Yoganathan automatically
Every clearance here is in the API, with alerts when new ones post.